American International Group, Inc. Nurix Therapeutics, Inc. Transaction History

American International Group, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$7.77 - $15.66 $1,561 - $3,147	-201 Reduced 0.85%	23,460 $344,000
Q4 2023 Feb 13, 2024	SELL	$4.25 - $10.71 $408 - $1,028	-96 Reduced 0.4%	23,661 $244,000
Q3 2023 Nov 13, 2023	BUY	$7.86 - $10.08 $9,463 - $12,136	1,204 Added 5.34%	23,757 $186,000
Q2 2023 Aug 04, 2023	BUY	$8.7 - $13.28 $1,374 - $2,098	158 Added 0.71%	22,553 $225,000
Q1 2023 May 12, 2023	BUY	$8.56 - $13.26 $3,817 - $5,913	446 Added 2.03%	22,395 $198,000
Q4 2022 Feb 10, 2023	SELL	$9.86 - $14.59 $778 - $1,152	-79 Reduced 0.36%	21,949 $241,000
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $15,733 - $25,277	1,276 Added 6.15%	22,028 $287,000
Q2 2022 Aug 12, 2022	BUY	$7.88 - $14.82 $40,991 - $77,093	5,202 Added 33.45%	20,752 $263,000
Q1 2022 May 13, 2022	SELL	$12.94 - $29.65 $14,156 - $32,437	-1,094 Reduced 6.57%	15,550 $218,000
Q4 2021 Feb 11, 2022	SELL	$26.43 - $34.5 $13,162 - $17,181	-498 Reduced 2.91%	16,644 $482,000
Q3 2021 Nov 12, 2021	SELL	$22.71 - $36.69 $9,265 - $14,969	-408 Reduced 2.32%	17,142 $514,000
Q2 2021 Aug 13, 2021	BUY	$24.21 - $35.89 $87,083 - $129,096	3,597 Added 25.78%	17,550 $466,000
Q1 2021 May 07, 2021	BUY	$26.98 - $50.17 $193,743 - $360,270	7,181 Added 106.04%	13,953 $434,000
Q4 2020 Feb 12, 2021	BUY	$22.85 - $48.44 $2,993 - $6,345	131 Added 1.97%	6,772 $223,000
Q3 2020 Nov 04, 2020	BUY	$16.05 - $34.91 $106,588 - $231,837	6,641 New	6,641 $232,000

181

68.1M

78K

53.8K

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $923M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.